media – Page 514 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Johnson & Johnson’s Darzalex snags landmark myeloma approval in first-line patients

EHR vendor Allscripts has made an agreement to purchase patient communication app maker Health Grid for $60 million in cash, with an additional $50 million in earnout payments based on Health Grid achieving certain revenue targets over the next three years, according to a recently registered SEC filing. The merger of the two companies is expected to close sometime during Q2 2018.
- Source: fiercepharma
- 577
- May 10, 2018
Darzalex Johnson & Johnson myeloma
World’s first Train Hospital helping rural Indian population

The Lifeline Express was introduced to meet two gaps: giving medical treatment in the remotest villages and providing lower-income people with free treatment. The train runs all over India, reaching the remotest places and halting in one place for a month before proceeding.
- Source: Ddu
- 638
- May 9, 2018
healthcare India Researches
NHS England moves to fast-track clinical trials

NHS England has unveiled new processes designed to fast track clinical trials undertaken across the NHS, and boost access for patients.
- Source: pharmatimes
- 604
- May 9, 2018
Clinical Trials NHS
Takeda, Japanese pharma giant clinched to Buy Shire for $61.50 billion

On Monday Takeda Pharmaceutical confirmed to acquire Shire for £45.3 billion ($61.50 billion). The final deal will be 46 percent cash and 54 percent stock.
- Source: business standard
- 686
- May 9, 2018
Market Views merger-and-acquisition Shire Takeda
Appointment booking app Solv Health raised $16.8 million

San Francisco-based appointment booking application Solv Health announced that it has raised $16.8 million in Series B funding from Greylock Partners, along with Benchmark and Aspect Ventures. The company also unveiled its new Solv Pay feature, which helps to make payment quicker and easier for its users.
- Source: drugdu
- 711
- May 9, 2018
Company Insights digital health healthcare
Mayo Clinic’s new mHealth app to detect Epilepsy

Mayo Clinic researchers found success with an mHealth app - EpiFinder, which can diagnose Epilepsy (A disruption in which nerve cell activity in the brain is disturbed, causing seizures). During recent research conducted at Mayo Clinic, the Epifinder app recognized epilepsy in almost 87percent of the cases.
- Source: drugdu
- 841
- May 9, 2018
epilepsy mHealth Researches
Boosted by China launch, Merck’s Gardasil turns in a big first-quarter performance

Merck generated more than $1.5 billion in first-quarter vaccine sales. (Merck)
- Source: fiercepharma
- 581
- May 9, 2018
Gardasil HPV vaccine Merck
First-line use of Roche’s Tecentriq given priority review

US regulators are undertaking a priority review of Roche unit Genentech’s PD-L1 inhibitor Tecentriq, in combination with Avastin and standard chemotherapy for some patients with lung cancer.
- Source: pharmatimes
- 628
- May 9, 2018
Chemotherapy lung cancer Roche Tecentriq
Lyra Health raised $45 million to improve digital behavioral health technology, to treat mental illness

Today, Digital behavioral health company, Lyra Health announced that it has raised $45 million in Series B funding in a new financing round including Tenaya Capital, Glynn Capital, Crown Ventures, and Casdin Capital, as well as returning funders Greylock Partners, Venrock, and Providence Ventures.
- Source: drugdu
- 520
- May 8, 2018
AI Company Insights Mental health
Mobile-Health applications and wearables, to improve medication Adherence

Consumers are depending on mHealth applications and wearable devices to improve their medication abidance.
- Source: Ddu
- 786
- May 8, 2018
digital health Market Views mHealth

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.